Larimar Therapeutics President, COO John B. Harlow Jr. files initial beneficial ownership statement

• Larimar Therapeutics filed an initial Form 3 for John B. Harlow Jr., president and COO, dated Sept. 29, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Larimar Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-410715), on October 01, 2026, and is solely responsible for the information contained therein.